A red blood cell distribution width (RDW) test is an important part of a complete blood count (CBC) test. It measures the range of red blood cell sizes in the body. A high RDW result can indicate anemia, inflammation, or other health conditions. In this article, we will discuss the meaning of a high RDW result, and its potential implications.
RDW is a measure of the range of red blood cell sizes in the body. It is usually expressed as a percentage. The size of red blood cells can vary from person to person, but a high RDW result indicates that the size of the red blood cells is unusually wide.
A high RDW result can indicate a number of possible health conditions. It can be a sign of anemia, which is a condition in which the body does not have enough healthy red blood cells. It can also be a sign of inflammation, which is a response of the body to infection or injury. In some cases, it can be a sign of a vitamin B12 or folate deficiency.
If a high RDW result is found on a CBC test, further tests may be needed to diagnose the cause. These tests may include a ferritin test to check for anemia, a C-reactive protein test to check for inflammation, and a vitamin B12 and folate test to check for deficiencies.
The treatment for a high RDW result will depend on the underlying cause. If the cause is anemia, iron supplements may be prescribed to increase the number of healthy red blood cells in the body. If the cause is inflammation, anti-inflammatory medication may be prescribed. If the cause is a vitamin B12 or folate deficiency, supplements may be prescribed.
A high RDW result can be a sign of several different health conditions. It is important to discuss any abnormal results with a doctor, who can order further tests to diagnose the cause. Depending on the underlying cause, treatment may involve iron supplements, anti-inflammatory medication, or vitamin B12 or folate supplements.
1.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
2.
The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.
3.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
1.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
2.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
5.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation